A remarkable fish fossil from Antarctica offers a clear view of early evolution. Koharalepis jarviki, a 380-million-year-old specimen, reve...

India's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...

A normal treadmill stress test can offer false reassurance, as a recent case revealed. A 55-year-old man with intermittent chest discomfort...

India's journey towards the right to die with dignity has seen major milestones. The Harish Rana case marks a significant step, applying th...

Mankind Pharma is set to enter India's semaglutide market soon. The drug's patent expires this month, opening doors for new players. Mankin...

Indian healthcare stocks surged following the Union Budget 2026 announcement of measures to boost medical tourism. The government plans to ...

Will Bryan Johnson never die? Tech entrepreneur makes a tall claim that he may never die. He is building a digital version of himself calle...

Dr Alka Patel, a 53-year-old GP from the UK, claims she has reversed her biological age to 23 using a six-step daily routine focused on lif...

Under the revised guidelines, candidates who have studied physics, chemistry, biology/biotechnology, along with English, as additional subj...

Mexican doctors have examined mysterious remains believed to be non-human beings, sparking speculation. The examination involved tests on t...

The Biocon boss says this book inspires the reader to delve deeper into the mysteries of cellular science.

Art works are a great way to raise children's interest in science.

The companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...

The emerging technology of bionics provides hope to millions around the world who cannot hear, see or move.

Mars could support life in the shape of methanogens, one of the simplest and oldest microorganisms found on Earth, a new study claims.

Intas Pharmaceutical today said it has launched 'Mabtas' a new low cost drug for treating cancer in India.

Outsourcing of diagnostics and lab-testing services to India has proved to be a non-starter as regulatory hurdles in US and UK make it mand...